Related Experiment Video
Updated: Aug 11, 2026
05:18
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
Radioimmunotherapy: recent results and future directions
R B Wilder1, G L DeNardo, S J DeNardo
1Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, CA, USA.
Summary
Radioimmunotherapy shows promise, achieving high response rates in B-cell non-Hodgkin's lymphoma. Ongoing research addresses challenges to potentially cure currently incurable malignancies.
Area of Science:
- Oncology
- Immunology
- Nuclear Medicine
Background:
- Radioimmunotherapy utilizes antibodies to target cancer cells.
- Key aspects include antibody structure, function, and production.
- Selection of appropriate radioisotopes is crucial for effective treatment.
Purpose of the Study:
- To review the current landscape of radioimmunotherapy.
- To examine antibody characteristics, radioisotope selection, and production methods.
- To discuss clinical results, challenges, toxicity, and future directions.
Main Methods:
- A comprehensive literature review of radioimmunotherapy.
- Emphasis placed on analyzing clinical outcomes and future research trajectories.
- Focus on identifying and addressing current challenges in the field.
Main Results:
- Complete response rates up to 50% observed in B-cell non-Hodgkin's lymphoma patients.
- Identified challenges include circulating free antigen, Fc receptor binding, and tumor penetration.
- Investigated solutions involve high-dose therapy, autologous bone marrow transplantation, novel radionuclides (yttrium 90, copper 67), and engineered antibodies.
Conclusions:
- Radioimmunotherapy is an emerging field with significant advancements.
- Continued research is essential to overcome existing challenges.
- The goal is to establish radioimmunotherapy as a curative option for certain cancers.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...